Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?

Introduction: The 2016 NICE clinical guideline 95 (CG95) demoted functional imaging to a second-line test following computed tomography coronary angiography (CTCA). Many cardiac CT services in the UK require substantial investment and growth to implement this. Chest pain services like ours are likel...

Full description

Bibliographic Details
Main Authors: Victoria Pettemerides, Thomas Turner, Conor Steele, Anita Macnab
Format: Article
Language:English
Published: BMC 2019-04-01
Series:Echo Research and Practice
Subjects:
Online Access:https://erp.bioscientifica.com/view/journals/echo/6/2/ERP-18-0082.xml
_version_ 1811291145870770176
author Victoria Pettemerides
Thomas Turner
Conor Steele
Anita Macnab
author_facet Victoria Pettemerides
Thomas Turner
Conor Steele
Anita Macnab
author_sort Victoria Pettemerides
collection DOAJ
description Introduction: The 2016 NICE clinical guideline 95 (CG95) demoted functional imaging to a second-line test following computed tomography coronary angiography (CTCA). Many cardiac CT services in the UK require substantial investment and growth to implement this. Chest pain services like ours are likely to continue to use stress testing for the foreseeable future. We share service evaluation data from our department to show that a negative stress echocardiogram can continue to be used for chest pain assessment. Methods: 1815 patients were referred to rapid access chest pain clinic (RACPC) between June 2013 and March 2015. 802 patients had stress echocardiography as the initial investigation. 446 patients had normal resting left ventricular (LV) systolic function and a negative stress echocardiogram. At least 24 months after discharge, a survey was carried out to detect major adverse cardiovascular events (MACE) (cardiac death, myocardial infarction, admission to hospital for heart failure or angina, coronary artery disease at angiography, revascularisation by angioplasty or coronary artery bypass grafting) within 2 years. Results: Overall, 351 patients were successfully followed up. The mean Diamond-Forrester (D-F) score and QRISK2 suggested a high pre-test probability (PTP) of coronary artery disease (CAD). There were nine deaths (eight non-cardiac deaths and one cardiac death). MACE occurred in four patients with a mean time of 17.5 months (11.6–23.7 months). The annual event rate was 0.6%. Conclusion: A negative stress echocardiogram can reliably reassure patients and clinicians even in high PTP populations with suspected stable angina. It can continue to be used to assess stable chest pain post CG95.
first_indexed 2024-04-13T04:25:07Z
format Article
id doaj.art-7f25874fb5db401fa64f309424a1515c
institution Directory Open Access Journal
issn 2055-0464
2055-0464
language English
last_indexed 2024-04-13T04:25:07Z
publishDate 2019-04-01
publisher BMC
record_format Article
series Echo Research and Practice
spelling doaj.art-7f25874fb5db401fa64f309424a1515c2022-12-22T03:02:35ZengBMCEcho Research and Practice2055-04642055-04642019-04-01621723https://doi.org/10.1530/ERP-18-0082Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?Victoria Pettemerides0Thomas Turner1Conor Steele2Anita Macnab3Manchester University Foundation Trust, North West Heart Centre, Wythenshawe Hospital, Manchester, UKUniversity of Manchester Faculty of Biology, Medicine and Health, Manchester, UKUniversity of Manchester Faculty of Biology, Medicine and Health, Manchester, UKManchester University Foundation Trust, North West Heart Centre, Wythenshawe Hospital, Manchester, UKIntroduction: The 2016 NICE clinical guideline 95 (CG95) demoted functional imaging to a second-line test following computed tomography coronary angiography (CTCA). Many cardiac CT services in the UK require substantial investment and growth to implement this. Chest pain services like ours are likely to continue to use stress testing for the foreseeable future. We share service evaluation data from our department to show that a negative stress echocardiogram can continue to be used for chest pain assessment. Methods: 1815 patients were referred to rapid access chest pain clinic (RACPC) between June 2013 and March 2015. 802 patients had stress echocardiography as the initial investigation. 446 patients had normal resting left ventricular (LV) systolic function and a negative stress echocardiogram. At least 24 months after discharge, a survey was carried out to detect major adverse cardiovascular events (MACE) (cardiac death, myocardial infarction, admission to hospital for heart failure or angina, coronary artery disease at angiography, revascularisation by angioplasty or coronary artery bypass grafting) within 2 years. Results: Overall, 351 patients were successfully followed up. The mean Diamond-Forrester (D-F) score and QRISK2 suggested a high pre-test probability (PTP) of coronary artery disease (CAD). There were nine deaths (eight non-cardiac deaths and one cardiac death). MACE occurred in four patients with a mean time of 17.5 months (11.6–23.7 months). The annual event rate was 0.6%. Conclusion: A negative stress echocardiogram can reliably reassure patients and clinicians even in high PTP populations with suspected stable angina. It can continue to be used to assess stable chest pain post CG95.https://erp.bioscientifica.com/view/journals/echo/6/2/ERP-18-0082.xmlstable chest paincoronary artery diseaseexercise echocardiographydobutamine stress echocardiography
spellingShingle Victoria Pettemerides
Thomas Turner
Conor Steele
Anita Macnab
Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?
Echo Research and Practice
stable chest pain
coronary artery disease
exercise echocardiography
dobutamine stress echocardiography
title Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?
title_full Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?
title_fullStr Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?
title_full_unstemmed Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?
title_short Does stress echocardiography still have a role in the rapid access chest pain clinic post NICE CG95?
title_sort does stress echocardiography still have a role in the rapid access chest pain clinic post nice cg95
topic stable chest pain
coronary artery disease
exercise echocardiography
dobutamine stress echocardiography
url https://erp.bioscientifica.com/view/journals/echo/6/2/ERP-18-0082.xml
work_keys_str_mv AT victoriapettemerides doesstressechocardiographystillhavearoleintherapidaccesschestpainclinicpostnicecg95
AT thomasturner doesstressechocardiographystillhavearoleintherapidaccesschestpainclinicpostnicecg95
AT conorsteele doesstressechocardiographystillhavearoleintherapidaccesschestpainclinicpostnicecg95
AT anitamacnab doesstressechocardiographystillhavearoleintherapidaccesschestpainclinicpostnicecg95